StockStory.org on MSN
Why Myriad Genetics (MYGN) Stock Is Down Today
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 19.3% in the morning session after it ...
StockStory.org on MSN
Myriad Genetics’s (NASDAQ:MYGN) Q3 Earnings Results: Revenue In Line With Expectations But Stock Drops
Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q3 CY2025, but sales fell by 3.6% year on year to $205.7 million.
Sophia Genetics has launched an artificial-intelligence-powered tool that creates virtual copies of patients, known as digital twins, that could one day be used to help doctors test the potential of ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third ...
Founded in 2021, T3 Molecular Genetics Pvt Ltd. (T-3MGen) operates in the Health Tech sector offering new therapeutic interventions through multi-disciplinary ...
The agri-biotech is developing a bovine IVF platform to deliver scalable, high-quality outcomes for cattle producers ...
News Medical on MSN
New gene-editing tech holds promise for treating complex genetic diseases
Researchers have developed an improved method of gene editing that is precise, more efficient than other similar methods and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results